Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM9SYVJ)

Drug Name
ABX-1431 Drug Info
Synonyms SQZJGTOZFRNWCX-UHFFFAOYSA-N; CHEMBL3945728; SCHEMBL15100632; BDBM180052; US9133148, 9aq
Indication
Disease Entry ICD 11 Status REF
Neuropathic pain 8E43.0 Phase 1 [1]
Tourette syndrome 8A05.00 Phase 1 [1]
Cross-matching ID
PubChem CID
71657619
CAS Number
CAS 1446817-84-0
TTD Drug ID
DM9SYVJ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Monoglyceride lipase (MAGL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID29053063-Compound-11d DMDRK68 N. A. N. A. Patented [2]
Piperazine carbamic compound 1 DMZSYU4 N. A. N. A. Patented [2]
Piperazine carbamic compound 2 DMMQ0ZO N. A. N. A. Patented [2]
Pyrazole derivative 82 DMETCI3 N. A. N. A. Patented [2]
Pyrazole derivative 81 DMWT437 N. A. N. A. Patented [2]
PMID29053063-Compound-15 DM07U5R N. A. N. A. Patented [2]
Pyrazole derivative 80 DMQ3TGM N. A. N. A. Patented [2]
Carbamide derivative 24 DMD6Y73 N. A. N. A. Patented [2]
Piperazine carbamic compound 4 DMKZUO4 N. A. N. A. Patented [2]
Carbamide derivative 26 DMDU9XF N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Monoglyceride lipase (MAGL) TTZ963I MGLL_HUMAN Inhibitor [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).Expert Opin Ther Pat. 2017 Dec;27(12):1341-1351.